List of The Wistar Institute patents

Patents where

Current Assignee

Name

The Wistar Institute

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9402888 Methods and compositions for treating cancer	Patent 9402888 was granted and assigned to The Wistar Institute on August, 2016 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	9402888	August 2, 2016
‌ US Patent 7217570 Organotypic intestinal culture and methods of use thereof	Patent 7217570 was granted and assigned to The Wistar Institute on May, 2007 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	7217570	May 15, 2007
‌ US Patent 7217532 Methods for detecting DNA damage and screening for cancer therapeutics	Patent 7217532 was granted and assigned to The Wistar Institute on May, 2007 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	7217532	May 15, 2007
‌ US Patent 10442763 EBNA1 inhibitors and methods using same	Patent 10442763 was granted and assigned to The Wistar Institute on October, 2019 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	10442763	October 15, 2019
‌ US Patent 9868951 Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells	Patent 9868951 was granted and assigned to The Wistar Institute on January, 2018 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	9868951	January 16, 2018
‌ US Patent 10981867 EBNA1 inhibitors and methods using same	Patent 10981867 was granted and assigned to The Wistar Institute on April, 2021 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	10981867	April 20, 2021
‌ US Patent 7544465 Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity	Patent 7544465 was granted and assigned to The Wistar Institute on June, 2009 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	7544465	June 9, 2009
‌ US Patent 7176293 Compositions and methods to enhance sensitivity of cancer cells to mitotic stress	Patent 7176293 was granted and assigned to The Wistar Institute on February, 2007 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	7176293	February 13, 2007
‌ US Patent 11395851 Epstein-Barr virus nucleic acid constructs and vaccines made therefrom, and methods of using same		The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	11395851	July 26, 2022
‌ US Patent 11524065 Large and small T antigens of merkel cell polyomavirus, nucleic acid constructs and vaccines made therefrom, and methods of using same	Patent 11524065 was granted and assigned to The Wistar Institute on December, 2022 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	11524065	December 13, 2022
‌ US Patent 7354589 Multiple antigenic agents and methods for using the same	Patent 7354589 was granted and assigned to The Wistar Institute on April, 2008 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	7354589	April 8, 2008
‌ US Patent 6852706 Methods and compositions for healing heart wounds	Patent 6852706 was granted and assigned to The Wistar Institute on February, 2005 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	6852706	February 8, 2005
‌ US Patent 7473414 Compositions and methods for wound healing	Patent 7473414 was granted and assigned to The Wistar Institute on January, 2009 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	7473414	January 6, 2009
‌ US Patent 11242317 EBNA1 inhibitors and their method of use	Patent 11242317 was granted and assigned to The Wistar Institute on February, 2022 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	11242317	February 8, 2022
‌ US Patent 9856214 EBNA1 inhibitors and their method of use	Patent 9856214 was granted and assigned to The Wistar Institute on January, 2018 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	9856214	January 2, 2018
‌ US Patent 8962816 Constructs for enhancing immune responses	Patent 8962816 was granted and assigned to The Wistar Institute on February, 2015 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	8962816	February 24, 2015
‌ US Patent 9068974 Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers	Patent 9068974 was granted and assigned to The Wistar Institute on June, 2015 by the United States Patent and Trademark Office.		The Wistar Institute	United States Patent and Trademark Office	9068974	June 30, 2015
‌ US Patent 10328146 Contructs for enhancing immune responses	Patent 10328146 was granted and assigned to The Wistar Institute on June, 2019 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	10328146	June 25, 2019
‌ US Patent 9920375 Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers	Patent 9920375 was granted and assigned to The Wistar Institute on March, 2018 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	9920375	March 20, 2018
‌ US Patent 11208468 Methods and compositions for treating melanoma	Patent 11208468 was granted and assigned to The Wistar Institute on December, 2021 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	11208468	December 28, 2021
‌ US Patent 10351851 Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells	Patent 10351851 was granted and assigned to The Wistar Institute on July, 2019 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	10351851	July 16, 2019
‌ US Patent 10238755 Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming	Patent 10238755 was granted and assigned to The Wistar Institute on March, 2019 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	10238755	March 26, 2019
‌ US Patent 11207402 Constructs for enhancing immune responses	Patent 11207402 was granted and assigned to The Wistar Institute on December, 2021 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	11207402	December 28, 2021
‌ US Patent 9903870 Methods and compositions for the diagnosis of ovarian cancer	Patent 9903870 was granted and assigned to The Wistar Institute on February, 2018 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	9903870	February 27, 2018
‌ US Patent 11248033 Methods and compositions for treating cancer	Patent 11248033 was granted and assigned to The Wistar Institute on February, 2022 by the United States Patent and Trademark Office.	The Wistar Institute	The Wistar Institute	United States Patent and Trademark Office	11248033	February 15, 2022

Results per page:

58 results

0 selected

58 results

0 selected